Inflammatory Myopathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-11
Clinical Trial Update: A Study of Imvotamab in Active, Refractory Idiopathic Inflammatory Myopathies [Phase 1]
A Phase 1 study of Imvotamab in active, refractory idiopathic inflammatory myopathies has been terminated (Status: TERMINATED).